DeutschNewstral
Article
Seattle Times on 2021-05-04 13:13
Vaccine sales power Pfizer through first quarter
Related news
Vaccine sales power Pfizer through first quarter - Tue, 04 May 2021 PSTThe Spokesman-Review- Pfizer hikes 2021 outlook after vaccine boosts sales, profitSeattle Times
- TPfizer posts narrower Q3 loss amid slumping Covid vaccine salesthestreet.com
Pfizer records $22bn COVID-19 vaccine sales in 2021punchng.com- BPfizer Expects $26B in Covid-19 Vaccine Sales This Yearbarrons.com
- Biopharmaceuticals power Pfizer in the first quarterSeattle Times
- BPfizer Increased Vaccine Sales Estimate After AstraZeneca and J&J Stumblesbarrons.com
Pfizer sees COVID-19 vaccine, therapeutic sales topping $50 billion in 2022timesofisrael.com
Pfizer 2Q numbers tumble and COVID-19 vaccine, treatment sales dry upseattletimes.com
The scientists who developed the Pfizer/BioNTech Covid-19 vaccine are a Turkish-German power coupleCNN- Pfizer rides Paxlovid sales to better-than-expected quarterSeattle Times
- Pfizer tops Q1 forecasts; vaccine sales slide as expectedseattletimes.com
- HPfizer Raises 2021 COVID-19 Vaccine Sales Forecast to $33.5Bhamodia.com
Pfizer Q1 profit, revenue soar on COVID-19 vaccine salesNew York Post- Pfizer expects $26 billion in 2021 sales from COVID vaccineNew York Post
- Moderna first-quarter profit triples on robust vaccine salesSeattle Times
Pfizer expects $15bn sales of Covid-19 vaccineBBC
[Ticker] Pfizer expects €22bn in vaccine sales this yeareuobserver.com